4//SEC Filing
Pang Phillip 4
Accession 0001628280-24-000169
CIK 0001706431other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 2:47 PM ET
Size
14.0 KB
Accession
0001628280-24-000169
Insider Transaction Report
Form 4
Pang Phillip
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-02$1.57/sh+13,576$21,382→ 220,409 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-02$0.85/sh−18,833$16,102→ 0 totalExercise: $0.85Exp: 2027-03-09→ Common Stock (18,833 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-02$1.53/sh−47,591$72,814→ 0 totalExercise: $1.53Exp: 2028-04-27→ Common Stock (47,591 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-02$1.57/sh−13,576$21,382→ 0 totalExercise: $1.57Exp: 2028-07-19→ Common Stock (13,576 underlying) - Exercise/Conversion
Common Stock
2024-01-02$1.53/sh+47,591$72,814→ 268,000 total - Exercise/Conversion
Common Stock
2024-01-02$0.85/sh+18,833$16,102→ 206,833 total
Footnotes (3)
- [F1]1/4 of the shares subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.
- [F2]1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vested in 36 equal monthly installments thereafter.
- [F3]1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vested in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001787370
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 2:47 PM ET
- Size
- 14.0 KB